Anatara Lifesciences Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Net Income	-1.95	-1.45	-2.02	-2.53	-2	Upgrade
Depreciation & Amortization	0	0	0.02	0.02	0.01	Upgrade
Stock-Based Compensation	0.09	0.03	0.05	0.07	0.12	Upgrade
Other Operating Activities	0.01	0.05	0.02	0	0	Upgrade
Change in Accounts Receivable	-0.36	0.33	-0.5	0.26	-0.14	Upgrade
Change in Accounts Payable	-0.04	-0.23	0.17	-0.03	-0.08	Upgrade
Change in Other Net Operating Assets	-0.01	0.01	-0.01	-0.03	-0.01	Upgrade
Operating Cash Flow	-2.27	-1.25	-2.26	-2.23	-2.1	Upgrade
Capital Expenditures	-	-	-0	-0.01	-0	Upgrade
Investment in Securities	-	0.05	-	-0.05	-	Upgrade
Investing Cash Flow	-	0.05	-0	-0.06	-0	Upgrade
Long-Term Debt Issued	0.4	-	-	-	-	Upgrade
Long-Term Debt Repaid	-	-	-0.02	-0.02	-0	Upgrade
Net Debt Issued (Repaid)	0.4	-	-0.02	-0.02	-0	Upgrade
Issuance of Common Stock	1.09	1.99	1.7	-	3.07	Upgrade
Repurchase of Common Stock	-	-	-	-	-0.04	Upgrade
Other Financing Activities	-0.1	-0.16	-0.19	-0.01	-0.18	Upgrade
Financing Cash Flow	1.39	1.83	1.49	-0.02	2.85	Upgrade
Net Cash Flow	-0.88	0.63	-0.77	-2.31	0.75	Upgrade
Free Cash Flow	-2.27	-1.25	-2.26	-2.24	-2.1	Upgrade
Free Cash Flow Margin	-234.36%	-193.69%	-	-	-	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	-0.02	-0.03	-0.03	Upgrade
Levered Free Cash Flow	-1.6	-0.74	-1.53	-1.27	-1.39	Upgrade
Unlevered Free Cash Flow	-1.6	-0.74	-1.53	-1.27	-1.39	Upgrade
Change in Working Capital	-0.41	0.12	-0.33	0.2	-0.23	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.